Genomics and Immunomics in the Treatment of Urothelial Carcinoma

Related Experiment Video

Updated: Sep 21, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

Veronica Mollica1, Francesco Massari1, Alessandro Rizzo2

  • 1Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, 40138 Bologna, Italy.

Current Oncology (Toronto, Ont.)
|May 27, 2022
PubMed

Insights

Genomic and immunomic drivers in urothelial carcinoma (bladder cancer) are key for treatment. Identifying targetable alterations with sequencing can guide personalized therapies and improve patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Immunology

Background:

  • Urothelial carcinoma is a complex malignancy.
  • Genomic and immunomic factors influence prognosis and treatment response.
  • Current immunotherapy benefits are established, but patient selection remains a challenge.

Purpose of the Study:

  • To explore the role of genomic and immunomic drivers in urothelial carcinoma.
  • To identify potential targetable alterations for precision medicine.
  • To optimize patient selection for immunotherapy and combination therapies.

Main Methods:

  • Next-generation sequencing (NGS) for genomic profiling.
  • RNA sequencing for transcriptomic analysis.
  • Integration of multi-omic data to identify therapeutic targets.

Main Results:

  • Genomic alterations and immunomic profiles correlate with disease characteristics.
  • Potential therapeutic targets were identified through multi-omic analysis.
  • Predictive biomarkers for immunotherapy response require further investigation.

Conclusions:

  • Precision medicine approaches utilizing genomic and immunomic data are crucial for advancing urothelial carcinoma treatment.
  • Targeted therapies and immunotherapies hold promise, but patient stratification is essential.
  • Further research is needed to refine treatment strategies and improve patient outcomes.
Keywords:
genomicsimmunotherapynext-generation sequencingurothelial cancer

More Related Videos

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.0K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K